BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

537253

SUNLOC

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SUNIL HEALTHCARE LTD Share Price Update

As of the latest trading session, SUNIL HEALTHCARE LTD share price is currently at ₹ 71.03, which is up by ₹ 0.01 from its previous closing. Today, the stock has fluctuated between ₹ 71.02 and ₹ 72.00. Over the past year, SUNIL HEALTHCARE LTD has achieved a return of -19.92 %. In the last month alone, the return has been -1.36 %. Read More...

SUNIL HEALTHCARE LTD fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    72.83

  • P/E Ratio (TTM)

    -7,102.00

  • Beta

    0.48

  • Book Value / share

    55.19

  • Return on equity

    -3.65%

  • EPS (TTM)

    0.00

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    -0.09

info icon alternate text

SUNIL HEALTHCARE LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 20.46
Operating Expense 20.91
Net Profit -0.09
Net Profit Margin (%) -0.43
Earnings Per Share (EPS) -0.09
EBITDA 3.69
Effective Tax Rate (%) 181.81
Particulars SEP 2024 (Values in Cr)
Revenue 20.26
Operating Expense 20.38
Net Profit 0.03
Net Profit Margin (%) 0.14
Earnings Per Share (EPS) 0.03
EBITDA 3.08
Effective Tax Rate (%) 57.14
Particulars JUN 2024 (Values in Cr)
Revenue 21.50
Operating Expense 21.54
Net Profit 0.01
Net Profit Margin (%) 0.04
Earnings Per Share (EPS) 0.01
EBITDA 3.05
Effective Tax Rate (%) 66.66
Particulars MAR 2024 (Values in Cr)
Revenue 21.31
Operating Expense 21.83
Net Profit 0.04
Net Profit Margin (%) 0.18
Earnings Per Share (EPS) 0.04
EBITDA 3.24
Effective Tax Rate (%) 20.00
Particulars DEC 2023 (Values in Cr)
Revenue 22.67
Operating Expense 26.20
Net Profit -0.37
Net Profit Margin (%) -1.63
Earnings Per Share (EPS) -0.36
EBITDA 2.33
Effective Tax Rate (%) 33.92
Particulars MAR 2024 (Values in Cr)
Revenue 89.69
Operating Expense 97.27
Net Profit -2.11
Net Profit Margin (%) -2.35
Earnings Per Share (EPS) -2.06
EBITDA 8.98
Effective Tax Rate (%) 26.73
Particulars MAR 2023 (Values in Cr)
Revenue 111.83
Operating Expense 103.70
Net Profit 6.98
Net Profit Margin (%) 6.24
Earnings Per Share (EPS) 6.80
EBITDA 20.93
Effective Tax Rate (%) 28.48
Particulars MAR 2022 (Values in Cr)
Revenue 116.37
Operating Expense 108.36
Net Profit 6.78
Net Profit Margin (%) 5.82
Earnings Per Share (EPS) 6.61
EBITDA 19.37
Effective Tax Rate (%) 29.15
Particulars MAR 2021 (Values in Cr)
Revenue 89.89
Operating Expense 95.16
Net Profit 0.28
Net Profit Margin (%) 0.31
Earnings Per Share (EPS) 0.27
EBITDA 11.77
Effective Tax Rate (%) 20.00
Particulars MAR 2020 (Values in Cr)
Revenue 70.13
Operating Expense 87.32
Net Profit -4.17
Net Profit Margin (%) -5.94
Earnings Per Share (EPS) -4.06
EBITDA 10.86
Effective Tax Rate (%) 29.27
Particulars MAR 2024 (Values in Cr)
Book Value / Share 49.71
ROE % -3.44
ROCE % 3.07
Total Debt to Total Equity 0.94
EBITDA Margin 10.32
Particulars MAR 2023 (Values in Cr)
Book Value / Share 51.73
ROE % 13.35
ROCE % 15.58
Total Debt to Total Equity 0.68
EBITDA Margin 18.71
Particulars MAR 2022 (Values in Cr)
Book Value / Share 45.84
ROE % 14.63
ROCE % 14.45
Total Debt to Total Equity 0.92
EBITDA Margin 16.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share 39.76
ROE % -1.50
ROCE % 5.04
Total Debt to Total Equity 1.12
EBITDA Margin 12.00
Particulars MAR 2020 (Values in Cr)
Book Value / Share 43.58
ROE % -10.85
ROCE % 1.37
Total Debt to Total Equity 1.13
EBITDA Margin 10.68
Particulars MAR 2024 (Values in Cr)
Book Value / Share 55.40
ROE % -3.65
ROCE % 2.62
Total Debt to Total Equity 0.85
EBITDA Margin 10.01
Particulars MAR 2023 (Values in Cr)
Book Value / Share 57.32
ROE % 12.62
ROCE % 15.00
Total Debt to Total Equity 0.61
EBITDA Margin 18.72
Particulars MAR 2022 (Values in Cr)
Book Value / Share 50.56
ROE % 13.99
ROCE % 14.07
Total Debt to Total Equity 0.84
EBITDA Margin 16.65
Particulars MAR 2021 (Values in Cr)
Book Value / Share 44.01
ROE % 0.71
ROCE % 5.90
Total Debt to Total Equity 1.07
EBITDA Margin 13.14
Particulars MAR 2020 (Values in Cr)
Book Value / Share 43.72
ROE % -8.88
ROCE % 2.11
Total Debt to Total Equity 1.10
EBITDA Margin 11.78
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 3.61
Total Assets 158.49
Total Liabilities 158.49
Total Equity 68.21
Share Outstanding 10254750
Price to Book Ratio 1.11
Return on Assets (%) -1.12
Return on Capital (%) -1.33
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.93
Total Assets 120.79
Total Liabilities 120.79
Total Equity 55.99
Share Outstanding 10254750
Price to Book Ratio 0.99
Return on Assets (%) 5.53
Return on Capital (%) 7.33
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 3.45
Total Assets 109.69
Total Liabilities 109.69
Total Equity 49.95
Share Outstanding 10254750
Price to Book Ratio 1.41
Return on Assets (%) 5.85
Return on Capital (%) 7.63
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 8.27
Total Assets 120.56
Total Liabilities 120.56
Total Equity 43.71
Share Outstanding 10254750
Price to Book Ratio 0.52
Return on Assets (%) -0.52
Return on Capital (%) -0.69
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 5.00
Total Assets 130.22
Total Liabilities 130.22
Total Equity 44.59
Share Outstanding 10254750
Price to Book Ratio 0.34
Return on Assets (%) -3.81
Return on Capital (%) -5.58
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 3.58
Total Assets 163.89
Total Liabilities 163.89
Total Equity 74.04
Share Outstanding 10254750
Price to Book Ratio 1.11
Return on Assets (%) -1.28
Return on Capital (%) -1.5
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.36
Total Assets 126.07
Total Liabilities 126.07
Total Equity 61.72
Share Outstanding 10254750
Price to Book Ratio 0.99
Return on Assets (%) 5.53
Return on Capital (%) 7.2
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 3.22
Total Assets 112.18
Total Liabilities 112.18
Total Equity 54.78
Share Outstanding 10254750
Price to Book Ratio 1.41
Return on Assets (%) 6.04
Return on Capital (%) 7.61
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 7.77
Total Assets 123.56
Total Liabilities 123.56
Total Equity 48.07
Share Outstanding 10254750
Price to Book Ratio 0.52
Return on Assets (%) 0.22
Return on Capital (%) 0.28
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 4.82
Total Assets 134.41
Total Liabilities 134.41
Total Equity 47.77
Share Outstanding 10254750
Price to Book Ratio 0.34
Return on Assets (%) -3.09
Return on Capital (%) -4.52
Particulars MAR 2024 (Values in Cr)
Net Income -2.55
Cash from Operations -14.63
Cash from Investing -10.11
Cash from Financing 25.00
Net change in Cash -0.50
Free Cash Flow -4.17
Particulars MAR 2023 (Values in Cr)
Net Income 9.48
Cash from Operations 8.84
Cash from Investing -3.40
Cash from Financing -3.74
Net change in Cash 0.32
Free Cash Flow 13.04
Particulars MAR 2022 (Values in Cr)
Net Income 9.26
Cash from Operations 23.70
Cash from Investing -4.23
Cash from Financing -18.55
Net change in Cash -0.28
Free Cash Flow 32.74
Particulars MAR 2021 (Values in Cr)
Net Income -0.55
Cash from Operations 16.82
Cash from Investing -11.35
Cash from Financing -6.41
Net change in Cash -0.78
Free Cash Flow 23.66
Particulars MAR 2020 (Values in Cr)
Net Income -6.59
Cash from Operations 4.40
Cash from Investing -2.51
Cash from Financing -1.56
Net change in Cash 0.23
Free Cash Flow 5.22
Particulars MAR 2024 (Values in Cr)
Net Income -2.88
Cash from Operations -13.58
Cash from Investing -10.61
Cash from Financing 25.00
Net change in Cash 0.03
Free Cash Flow -3.12
Particulars MAR 2023 (Values in Cr)
Net Income 9.75
Cash from Operations 8.49
Cash from Investing -3.40
Cash from Financing -3.74
Net change in Cash -0.01
Free Cash Flow 12.69
Particulars MAR 2022 (Values in Cr)
Net Income 9.57
Cash from Operations 23.06
Cash from Investing -3.34
Cash from Financing -18.55
Net change in Cash -0.01
Free Cash Flow 32.10
Particulars MAR 2021 (Values in Cr)
Net Income 0.34
Cash from Operations 16.44
Cash from Investing -11.32
Cash from Financing -6.41
Net change in Cash -1.11
Free Cash Flow 23.28
Particulars MAR 2020 (Values in Cr)
Net Income -5.81
Cash from Operations 4.26
Cash from Investing -2.45
Cash from Financing -1.54
Net change in Cash 0.18
Free Cash Flow 5.08
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6992.60 76.74 13.41 100542.86 5690.80 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 78.74 192.05 4.94 147.57 51.01 / 98.70
SHREE PACETRONIX LTD. 71.00 14.79 1.90 25.56 61.11 / 268.50
TRANSGENE BIOTEK LTD. 3.75 0.00 2.62 28.41 3.22 / 10.84
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6992.60 83.66 12.27 100542.86 5690.80 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 31.25 0.00 -16.74 23.34 28.34 / 59.90
KOVAI MEDICAL CENTER & HOSPITA 5584.95 29.60 6.27 6109.94 3750.00 / 6400.00

SUNIL HEALTHCARE LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
71.03 0.01 redarrow
red-green-graph indicator
14 Bearish
2 Bullish
  • 5 Days 72.30
  • 26 Days 71.50
  • 10 Days 72.20
  • 50 Days 72.00
  • 12 Days 72.10
  • 100 Days 74.30
  • 20 Days 71.60
  • 200 Days 75.90
72.09 PIVOT

First Support

69.18

First Resistance

73.93

Second Support

67.34

Second Resistance

76.84

Third Support

64.43

Third Resistance

78.68

RSI

49.21

ADX

26.59

MACD

0.76

Williams % R

-46.17

Commodity Channel Index (CCI)

18.14

Date

2025-04-29

Week

824.00

Same Day

193.00

Month

661.00

1 Year

0.48

3 Year

0.46

Over 1 Month

-1.36%

down

Over 1 Year

-19.92%

down

Over 3 Months

5.33%

down

Over 3 Years

0.62%

down

Over 6 Months

-13.39%

down

Over 5 Years

31.61%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

SUNIL HEALTHCARE LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
26.36%
Promoter Holdings
73.52%
FII
0.0%
DII
0.1%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Anil Kumar Khaitan 5942494.0 (57.95%) Shareholding of Promoter and Promoter Group
Magnum Computers Private Limited 1327211.0 (12.94%) Shareholding of Promoter and Promoter Group
Shailesh Kumar 601416.0 (5.86%) Public Shareholding
Sunloc Foods Private Limited 543690.0 (5.3%) Public Shareholding
Magadh Traders Ltd 158066.0 (1.54%) Public Shareholding
Kanchan Sunil Singhania 123638.0 (1.21%) Public Shareholding

News

Left Arrow
Right Arrow

SUNIL HEALTHCARE LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

SUNIL HEALTHCARE LTD Share Price

Sunil Healthcare Limited (Formerly known Sunil Synchem Ltd) was incorporated in 1973. The Company introduced plant at Alwar; Rajasthan for manufacture of Empty Hard Gelatin Capsule Shells and HPMC Capsules Shell. With continuous efforts and improvements in policy & adherence to top-notch quality monitoring measures, the Company became the second-largest manufacturer of Empty Hard Gelatin Capsules (EHGC) in India.

The Company is WHO-GMP certified Company and has also been recognized as 'Star Export House' by GoI. The Company commenced its manufacturing operation in 1976 with installed capacity of 200 million Hard Gelatin Capsule Shell. With gradual expansion, it reached to the installed capacity of 10930 million capsules p.a. The product of the Company Hard Gelatin Capsule Shell is used by Pharmaceutical and Food supplement Companies as a container for administering medicines and food supplements. Therefore, the growth of the industry is dependent on the growth of pharmaceutical and food supplement companies domestically and globally.

The Company forayed into the Food Business with intention of setting up an integrated nut complex. Currently it is engaging in market survey and supply chain establishment by markets its products under the 'Sunloc Foods' brand name. Sunloc food is a division of the Company. which offer host of product ranging from food products, procurement of raw and processed Edible Nuts e. g, cashew nuts, almonds, pistachios, walnuts etc. It has identified Raw Cashew nut, Dehydrated Vegetables, Cashew nuts, Saffron, cardamom, Almonds, Pistachio and Walnuts as major food item to generate the business under this division. Further, it has identified 'Raw Cashew Nuts (RCN) as major product of cashew nuts in world. RCN is imported from West African Countries like Benin, Guinea Bissau, Ghana, and Indonesia etc. and is sold in India and other countries.

During the year 2016-17, the Company set up a Wholly Owned Subsidiary namely 'Sunil Healthcare North America LLC' in the United
States of America on 26th July, 2016 and a subsidiary 'Sunil Healthcare Mexico SA DE CV'' in the city of San Luis Postosi, Mexico, United Mexican States on 1st February, 2017.

The Company increased production capacity of manufacturing of Empty Hard Gelatin Capsule from 10 billion to 11 billion (appox) p.a. in 2016-17 within the existing infrastructure of land and other utilities thereby, achieving economies of scale.

The Company increased production capacity of manufacturing of Empty Hard Gelatin Capsule from 11 billion to 13 billion (appox) p.a. in 2017-18. It started production of HPMC Capsule in August 2018.

During the year 2021-22, the production capacity of manufacturing of Empty Hard Capsule shell increased to 15 billion p.a.

Parent organization Satya
NSE symbol [-]
Founded 1973
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Sunil Healthcare Ltd?

Answer Field

The share price of Sunil Healthcare Ltd for NSE is ₹ 0.00 and for BSE is ₹ 71.03.

What is the Market Cap of Sunil Healthcare Ltd?

Answer Field

The market cap of Sunil Healthcare Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 72.80 Cr. as of now.

What is the 52 Week High and Low of Sunil Healthcare Ltd?

Answer Field

The 52 Week High and Low of Sunil Healthcare Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 104.00 and ₹ 60.55.

How to Buy Sunil Healthcare Ltd share?

Answer Field

You can trade in Sunil Healthcare Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Sunil Healthcare Ltd?

Answer Field

The 1 year returns on the stock has been -23.72%.

What is the Current Share Price of Sunil Healthcare Ltd?

Answer Field

Sunil Healthcare Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 71.03 as on Apr 30 2025 01:12 PM.

What is the Market Cap of Sunil Healthcare Ltd Share?

Answer Field

The market cap of Sunil Healthcare Ltd for NSE ₹ 0.0 & for BSE ₹ 72.80 as on Apr 30 2025 01:12 PM.

What is the P/E Ratio of Sunil Healthcare Ltd Share?

Answer Field

As on Apr 30 2025 01:12 PM the price-to-earnings (PE) ratio for Sunil Healthcare Ltd share is -7102.00.

What is the PB ratio of Sunil Healthcare Ltd Share?

Answer Field

As on Apr 30 2025 01:12 PM, the price-to-book (PB) ratio for Sunil Healthcare Ltd share is 55.19.

How to Buy Sunil Healthcare Ltd Share?

Answer Field

You can trade in Sunil Healthcare Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Sunil Healthcare Ltd Share on Bajaj Broking App?

Answer Field

To buy Sunil Healthcare Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Sunil Healthcare Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|